Kongressthemen
The past twelve months have culminated in an unprecedented level of excitement, investment, and clinical progress within the gene therapy field. As the field strives to strike a delicate balance between safety and efficacy, in the context of increased regulatory scrutiny and safety challenges, attending the 4th Annual Gene Therapy Analytical Development as an analytical scientist has never been so important.
Wissenschaftliche Fach-Gesellschaft
Hanson Wade
Anmerkungen
Speakers: Adebowale Shoroye, Scientist, Biogen, Alexander Wong, Principal Research Associate, Sanofi Genzyme, Andrea Hamilton, Associate Director, Quality Control, Gyroscope Therapeutics
https://go.evvnt.com/1259027-2?pid=4832
Frau Emily Birt
KategorienGesundheitsversorgung, Public Health
